- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.It is the largest pharmaceutical company in India.
Sun Pharmaceutical Industries will participate in multiple analyst/institutional investor meetings in September, including the UBS India Summit, Jefferies India Forum, Kotak Institutional Equities Healthcare Forum, J.P. Morgan India Conference, and Anand Rathi Annual Flagship Conference G-200 Summit. These will be physical group and one-on-one interactions.
Sun Pharmaceutical Industries Limited will hold physical group and one-on-one meetings with analysts and institutional investors on September 1, 2026. This will take place at the Ashwamedh – Elara India Dialogue 2026 event in Mumbai. No Unpublished Price Sensitive Information will be disclosed during these sessions.